Johannes, C. B., Beachler, D. C., Layton, J. B., Danysh, H. E., Ziemiecki, R. ., Arana, A. ., … Gilsenan, A. . (2022). Post-Authorization Safety Study of Hospitalization for Acute Kidney Injury in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug Saf. http://doi.org/10.1007/s40264-022-01263-3
P. Hunt
First name
P.
Middle name
R.
Last name
Hunt
Danysh, H. E., Johannes, C. B., Beachler, D. C., Layton, J. B., Ziemiecki, R. ., Arana, A. ., … Gilsenan, A. . (2022). Post-Authorization Safety Studies of Acute Liver Injury and Severe Complications of Urinary Tract Infection in Patients with Type 2 Diabetes Exposed to Dapagliflozin in a Real-World Setting. Drug Saf. http://doi.org/10.1007/s40264-022-01262-4
Desai, U. ., . Y. Kirson, N. ., Kim, J. ., Khunti, K. ., King, S. ., Trieschman, E. ., … Mukherjee, J. . (2018). Time to Treatment Intensification After Monotherapy Failure and Its Association With Subsequent Glycemic Control Among 93,515 Patients With Type 2 Diabetes. Diabetes Care. http://doi.org/10.2337/dc17-0662
Cherney, D. Z. I., Repetto, E. ., Wheeler, D. C., Arnold, S. V., MacLachlan, S. ., Hunt, P. R., … Kosiborod, M. . (2019). Impact of Cardio-Renal-Metabolic Comorbidities on Cardiovascular Outcomes and Mortality in Type 2 Diabetes Mellitus. Am J Nephrol. http://doi.org/10.1159/000504558